DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
544445 logo

Asston Pharmaceuticals Limited Stock Price

BSE:544445 Community·₹1.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

544445 Share Price Performance

₹109.00
2.75 (2.59%)
​
₹109.00
2.75 (2.59%)
​
Price ₹109.00
Sun, 13 Sep 26
Share Pricen/a

544445 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
1 Reward
View Full Analysis

Asston Pharmaceuticals Limited Key Details

₹254.7m

Revenue

₹174.1m

Cost of Revenue

₹80.6m

Gross Profit

₹41.9m

Other Expenses

₹38.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
3.54
31.63%
15.18%
13.1%
View Full Analysis

About 544445

Founded
2019
Employees
46
CEO
Saili More
WebsiteView website
www.asstonpharmaceuticals.com

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hydrochloride sustained release, metformin hydrochloride, metronidazole, multivitamin, nitrofurantoin, ofloxacin and ornidazole, pantoprazole, paracetamol, paracetamol, phenylephrine HCL, chlorpheniramine maleate and caffeine, prednisolone, pregabalin SR and methylcobalamin, rifampicin and isoniazid, rifampicin, isoniazid, pyrazinamide and ethambutol HCL, sildenafil, tadalafil, telmisartan, and zinc sulphate. It also offers capsules, including amoxicillin, ampicillin and cloxacillin, ampicillin, b-complex, cloxacillin, danazol, diclofenac, ibuprofen, paracetamol, caffeine, indomethacin, itraconazole, mecobalamin, alpha lipoic acid, thiamine mononitrate, pyridoxine HCL and folic acid, mefenamic acid, multivitamin, omeprazole, pregabalin, rabeprazole sodium and domperidone SR, rifabutin, and rifampicin; and oral suspension and syrup, which includes albendazole, amodiaquine, antacid, artemether and lumefantrine dry, azithromycin dry, b-complex, cefixime dry, chloroquine, co-trimoxazole, iron, kids cold, kids cough, mebendazole, metronidazole, multivitamin, and paracetamol. In addition, the company provides sachets and oral powder comprising oral rehydration salt, vitamin d3, glucose powder, sorbitol powder, prebiotic and probiotic, and antacids. It sells its products in the form of tablet capsules, syrup, sachet, and injection. The company was incorporated in 2019 and is based in Navi Mumbai, India.

Recent 544445 News & Updates

Recent updates

No updates

Asston Pharmaceuticals Limited Competitors

GLENMARK logo

Glenmark Pharmaceuticals

Symbol: NSEI:GLENMARK
Market cap: ₹682.7b
BIOCON logo

Biocon

Symbol: NSEI:BIOCON
Market cap: ₹632.7b
ALKEM logo

Alkem Laboratories

Symbol: NSEI:ALKEM
Market cap: ₹608.3b
500488 logo

Abbott India

Symbol: BSE:500488
Market cap: ₹543.7b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide